Wolverine Trading, LLC Sarepta Therapeutics, Inc. Transaction History
Wolverine Trading, LLC
- $133 Billion
- Q3 2025
A detailed history of Wolverine Trading, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 16,719 shares of SRPT stock, worth $314,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,719
Previous 13,900
20.28%
Holding current value
$314,484
Previous $237,000
35.86%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding SRPT
# of Institutions
411Shares Held
153MCall Options Held
5.44MPut Options Held
6.09M-
Paul Tudor Jones Tudor Investment Corp Et Al | Stamford, Ct68.8MShares$1.29 Billion0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$194 Million0.04% of portfolio
-
State Street Corp Boston, MA5.3MShares$99.8 Million0.0% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.69MShares$50.5 Million0.49% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.65B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...